ARTICLE | Company News
Oxagen, Oxford University deal
October 22, 2001 7:00 AM UTC
Oxagen received an exclusive license to the university's patents covering gene polymorphisms in asthma, psoriasis, inflammatory bowel disease and autoimmune thyroid disease. One patent, Oxagen said, c...